These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

324 related items for PubMed ID: 21279352

  • 21. Comparison of 123I-MIBG SPECT-CT and 18F-DOPA PET-CT in the evaluation of patients with known or suspected recurrent paraganglioma.
    Rufini V, Treglia G, Castaldi P, Perotti G, Calcagni ML, Corsello SM, Galli G, Fanti S, Giordano A.
    Nucl Med Commun; 2011 Jul; 32(7):575-82. PubMed ID: 21471850
    [Abstract] [Full Text] [Related]

  • 22. 68Ga-DOTA-Tyr3-octreotide PET in neuroendocrine tumors: comparison with somatostatin receptor scintigraphy and CT.
    Gabriel M, Decristoforo C, Kendler D, Dobrozemsky G, Heute D, Uprimny C, Kovacs P, Von Guggenberg E, Bale R, Virgolini IJ.
    J Nucl Med; 2007 Apr; 48(4):508-18. PubMed ID: 17401086
    [Abstract] [Full Text] [Related]

  • 23. Role of [68Ga]DOTANOC PET/computed tomography and [131I]MIBG scintigraphy in the management of patients with pheochromocytoma and paraganglioma: a prospective study.
    Singh D, Shukla J, Walia R, Vatsa R, Paul N, Chhabra A, Nahar U, Singh H, Kumar R, Bhansali A, Rai Mittal B.
    Nucl Med Commun; 2020 Oct; 41(10):1047-1059. PubMed ID: 32732602
    [Abstract] [Full Text] [Related]

  • 24. Diagnostic accuracy of (68)Ga-DOTANOC PET/CT imaging in pheochromocytoma.
    Sharma P, Dhull VS, Arora S, Gupta P, Kumar R, Durgapal P, Malhotra A, Chumber S, Ammini AC, Kumar R, Bal C.
    Eur J Nucl Med Mol Imaging; 2014 Mar; 41(3):494-504. PubMed ID: 24158184
    [Abstract] [Full Text] [Related]

  • 25. Comparison of diagnostic value of I-123 MIBG and high-dose I-131 MIBG scintigraphy including incremental value of SPECT/CT over planar image in patients with malignant pheochromocytoma/paraganglioma and neuroblastoma.
    Fukuoka M, Taki J, Mochizuki T, Kinuya S.
    Clin Nucl Med; 2011 Jan; 36(1):1-7. PubMed ID: 21157198
    [Abstract] [Full Text] [Related]

  • 26. Evaluation of (68)Ga-DOTA-TOC PET/CT for the detection of duodenopancreatic neuroendocrine tumors in patients with MEN1.
    Morgat C, Vélayoudom-Céphise FL, Schwartz P, Guyot M, Gaye D, Vimont D, Schulz J, Mazère J, Nunes ML, Smith D, Hindié E, Fernandez P, Tabarin A.
    Eur J Nucl Med Mol Imaging; 2016 Jul; 43(7):1258-66. PubMed ID: 26819103
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. PET/CT imaging in neuroblastoma.
    Piccardo A, Lopci E, Conte M, Foppiani L, Garaventa A, Cabria M, Villavecchia G, Fanti S, Cistaro A.
    Q J Nucl Med Mol Imaging; 2013 Mar; 57(1):29-39. PubMed ID: 23474633
    [Abstract] [Full Text] [Related]

  • 31. 68Ga-DOTATATE PET/CT Compared with 131I-MIBG SPECT/CT in the Evaluation of Neural Crest Tumors.
    Shahrokhi P, Emami-Ardekani A, Harsini S, Eftekhari M, Fard-Esfahani A, Fallahi B, Karamzade Ziarati N, Akhlaghi M, Farzanefar S, Hashemi Taheri AP, Beiki D.
    Asia Ocean J Nucl Med Biol; 2020 Mar; 8(1):8-17. PubMed ID: 32064278
    [Abstract] [Full Text] [Related]

  • 32. Functional imaging in neuroendocrine tumors: assessment of molecular heterogeneity using [68Ga]Ga-DOTA-TOC and [18F]FDG PET/CT.
    Nogareda Seoane Z, Mallón Araújo MC, Calatayud Cubes A, Barberán Corral C, Domínguez Novoa Y, Cousillas Castiñeira A, Martínez Lago N, de Matías Leralta JM, Pubul Nuñez V.
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2024 Mar; 43(3):500011. PubMed ID: 38643835
    [Abstract] [Full Text] [Related]

  • 33. Review: The Role of Radiolabeled DOTA-Conjugated Peptides for Imaging and Treatment of Childhood Neuroblastoma.
    Alexander N, Vali R, Ahmadzadehfar H, Shammas A, Baruchel S.
    Curr Radiopharm; 2018 Mar; 11(1):14-21. PubMed ID: 29243585
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.